BIOVIE INC. — Investor Relations & Filings
BioVie Inc. is a clinical-stage biopharmaceutical company that develops drug therapies for chronic debilitating conditions. The company's pipeline focuses on neurological and neurodegenerative disorders as well as advanced liver disease. Its lead drug candidate, bezisterim, is being studied for Alzheimer's disease based on the hypothesis that modulating inflammation and enhancing insulin sensitivity in the brain can improve cognitive function and provide neuroprotection. Other areas of focus include Parkinson's disease, ascites (a common complication of advanced liver cirrhosis), and Long COVID. The company also conducts research into epigenetic mechanisms, such as DNA methylation, to understand gene expression regulation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - BIOVIE INC. (0001580149) (Filer) | 2026-05-11 | English | |
| SCHEDULE 13D - BIOVIE INC. (0001580149) (Subject) | 2026-03-25 | English | |
| 10-Q Filing | 2026-02-06 | English | |
| Director's Dealing 2026 | 2026-01-09 | English | |
| Director's Dealing 2026 | 2026-01-09 | English | |
| Director's Dealing 2026 | 2026-01-09 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 45001021 | 10-Q - BIOVIE INC. (0001580149) (Filer) | 2026-05-11 | English | ||
| 33043004 | SCHEDULE 13D - BIOVIE INC. (0001580149) (Subject) | 2026-03-25 | English | ||
| 30698222 | 10-Q Filing | 2026-02-06 | English | ||
| 12689124 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689125 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689126 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689127 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689128 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689129 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689130 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689131 | Director's Dealing 2026 | 2026-01-09 | English | ||
|
2025
4 filings
| |||||
| 12689132 | FORM S-8 | 2025-11-25 | English | ||
| 12689133 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 12689134 | CURRENT REPORT | 2025-11-13 | English | ||
| 12689135 | CURRENT REPORT | 2025-11-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
BIOVIE INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35090/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35090 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35090 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35090 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35090}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOVIE INC. (id: 35090)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.